The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sutro Biopharma, Inc(NASDAQ:STRO) 
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's prod...
Sutro Biopharma Days Payable Outstanding ttm (DPO)
Sutro Biopharma Days Receivable Outstanding ttm (DSO)
Sutro Biopharma Op Cashflow Per Share ttm
Sutro Biopharma Free Cashflow Per Share ttm
Sutro Biopharma Cash Per Share ttm
Sutro Biopharma P/S ratio ttm
Sutro Biopharma (GAAP) P/E ratio ttm
Sutro Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.